Tens of thousands of HIV patients could soon to be offered a monthly pill to control the virus and keep the virus at bay. Results from a landmark trial show the drug was as effective as the daily cocktail of pills patients currently take. Experts claim the new pill, known as a nucleoside reverse transcriptase translocation inhibitor (NRTTI), could fulfill an 'unmet need' and replace the daily pills, improving compliance.
The Sussex Beacon, a Brighton-based charity supporting those living with HIV, has announced it is set to become the UK's first-ever dedicated hospice for the queer community in Sussex.
In December 2023, his conviction for causing serious harm to two partners by intentionally or recklessly infecting them with HIV was quashed by the Supreme Court.
"I didn't physically take care of him, and I wasn't a nurse or anything like that, but I definitely helped, certainly after the accident. I helped organize and sort of focus Chris on a different set of priorities than he probably had before his accident."
"It's a milestone moment in the history of HIV," says Daniel O'Day, chairman and CEO of Gilead Sciences. "In our opinion, it's the best tool yet in helping end the HIV epidemic for everyone, everywhere."
It seemed like it was all just for nothing. Dozens of health trials across Africa were forced to grind to an abrupt halt in late January after US President Donald Trump pulled the plug on millions of dollars in funding without warning.